These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 17460590

  • 1. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration.
    Pece A, Isola V, Vadalà M, Calori G.
    Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590
    [Abstract] [Full Text] [Related]

  • 2. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
    Axer-Siegel R, Ehrlich R, Rosenblatt I, Kramer M, Priel E, Yassur Y, Weinberger D.
    Arch Ophthalmol; 2004 Apr; 122(4):453-9. PubMed ID: 15078661
    [Abstract] [Full Text] [Related]

  • 3. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
    Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F.
    Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [Abstract] [Full Text] [Related]

  • 5. Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.
    Axer-Siegel R, Ehrlich R, Avisar I, Kramer M, Rosenblatt I, Priel E, Weinberger D.
    Ophthalmic Surg Lasers Imaging; 2006 Oct; 37(6):455-61. PubMed ID: 17152538
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy with verteporfin for retinal angiomatous proliferation.
    Boscia F, Parodi MB, Furino C, Reibaldi M, Sborgia C.
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1224-32. PubMed ID: 16525824
    [Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment.
    Saito M, Iida T, Nagayama D.
    Br J Ophthalmol; 2008 Dec; 92(12):1642-7. PubMed ID: 18782798
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
    Costa RA, Jorge R, Calucci D, Melo LA, Cardillo JA, Scott IU.
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [Abstract] [Full Text] [Related]

  • 10. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
    Verteporfin In Photodynamic Therapy Study Group.
    Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
    [Abstract] [Full Text] [Related]

  • 11. ICG angiography-guided photodynamic therapy for large pigment epithelial detachments in age-related macular degeneration.
    Wygnanski-Jaffe T, Desatnik H, Alhalel A, Goldstein M, Lowenstein A, Zolf R, Moisseiev J.
    Ophthalmic Surg Lasers Imaging; 2006 May; 37(5):358-63. PubMed ID: 17017194
    [Abstract] [Full Text] [Related]

  • 12. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
    Browning AC, Chung AK, Ghanchi F, Harding SP, Musadiq M, Talks SJ, Yang YC, Amoaku WM, United Kingdom PDT Users Group.
    Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
    [Abstract] [Full Text] [Related]

  • 13. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [Abstract] [Full Text] [Related]

  • 14. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R, Gabric N.
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [Abstract] [Full Text] [Related]

  • 15. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [Abstract] [Full Text] [Related]

  • 17. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Della Corte M, Rinaldi M, Romano M, Dell'omo R, Costagliola C.
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [Abstract] [Full Text] [Related]

  • 18. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
    Pece A, Vadalà M, Isola V, Matranga D.
    Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
    [Abstract] [Full Text] [Related]

  • 19. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES.
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [Abstract] [Full Text] [Related]

  • 20. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
    Kaiser PK, Registry of Visudyne AMD Therapy Writing Committee, Boyer DS, Garcia R, Hao Y, Hughes MS, Jabbour NM, Kaiser PK, Mieler W, Slakter JS, Samuel M, Tolentino MJ, Roth D, Sheidow T, Strong HA.
    Ophthalmology; 2009 Apr; 116(4):747-55, 755.e1. PubMed ID: 19243834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.